Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02053701 · ClinicalTrials.gov registry record

High-field Brain Magnetic Resonance Spectroscopy

A clinical trial of Healthy, sponsored by University of Minnesota.

Active
Registry status
30
Enrollment target
1
Study location

NCT02053701 is a study of Healthy that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 30 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02053701, a study of Healthy, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
30 participants
Enrollment target
1
Study location

Study Summary

Magnetic resonance spectroscopy (MRS) allows non-invasive measurement of the concentration of up to 18 metabolites in the brain ("neurochemical profile"). The objective of this proposal is to develop new methods for high-field brain MRS (3 to 7 Tesla). Our main hypothesis is that higher magnetic fields lead to improved spatial and temporal resolution and improved quantification precision. Aims 1. To obtain improved "neurochemical profiles" in the brain using single voxel proton MRS at very high field (3 Tesla to 7 Tesla). 2. To develop new methods for proton magnetic resonance spectroscopic imaging (MRSI) to obtain metabolic maps at very high field (3 Tesla to 7 Tesla). Since this project is focused on technical development, only healthy volunteers will be recruited (no patients).

Conditions Studied

Study Locations (1)

Minnesota

  • Center for Magnetic Resonance Research - Minneapolis

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2010-06-01
Est. Completion 2030-11

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT02053701

The ClinicalTrials.gov registry entry for NCT02053701 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (95% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 0 interventions.

NCT02053701 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT02053701 about?

NCT02053701 is a clinical study titled "High-field Brain Magnetic Resonance Spectroscopy". Magnetic resonance spectroscopy (MRS) allows non-invasive measurement of the concentration of up to 18 metabolites in the brain ("neurochemical profile"). The objective of this proposal is to develop new methods for high-field brain MRS (3 to 7 Tesla). Our main hypothesis is that higher magnetic f...

What is the current status of trial NCT02053701?

This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2010-06-01. Estimated completion is 2030-11.

What conditions does trial NCT02053701 study?

This clinical trial studies the following conditions: Healthy.

Who is sponsoring clinical trial NCT02053701?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02053701 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.